The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole ...
FREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision ...
On Wednesday, Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC has begun manufacturing the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male ...
Coloplast A/S is about to launch a new single-use male intermittent catheter featuring new technology designed to reduce the risk of urinary tract infections (UTI). “The Luja device, with its ...
image: Avoiding the unnecessary use of indwelling catheters and promptly removing catheters that are no longer needed are the first steps in preventing catheter-associated urinary tract infections in ...
Urinary tract infections (UTIs) are increasingly common in men, especially with age, posing serious health risks like blood ...
In a large retrospective analysis, midline catheters were associated with markedly lower risk of bloodstream infection and occlusion compared with peripherally inserted central catheters (PICCs). Data ...
Urinary catheters may be used by people who have problems passing urine. Long-term use is when a person uses a urinary catheter for at least 4 weeks. People who use a urinary catheter are at increased ...
Advancements in medical technology have led to the development of innovative medical devices that are doing things once far out of reach for improved patient care and outcomes. Image Credit: Amphenol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback